Regulation of S1P receptors and sphingosine kinases expression in acute pulmonary endothelial cell injury

PeerJ

Volumn 2016, Issue 12, 2016, Pages

  Liu, Huiying ^a   Zhang, Zili ^a   Li, Puyuan ^a   Yuan, Xin ^a   Zheng, Jing ^a   Liu, Jinwen ^b   Bai, Changqing ^a   Niu, Wenkai ^a  

^a Beijing 307 Hospital   (China)

^b Beijing Oriental Yamei Gene Science and Technology Research Institute Co LTD   (China)

Author keywords

Acute pulmonary endothelial cell injury; Mesenchymal; S1p receptors; Sphingosine 1 phosphate; Stem cells

Indexed keywords

BETA ACTIN; LIPOPOLYSACCHARIDE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; GENETIC REGULATION; HUMAN; HUMAN CELL; IMPEDANCE; LUNG ALVEOLUS CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

EID: 85004190372     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.2712     Document Type: Article

References (26)

1. Blaho VA, Hla T. 2014. An update on the biology of sphingosine 1-phosphate receptors. Journal of Lipid Research 55:1596-1608 DOI 10.1194/jlr.R046300.
2. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. New England Journal of Medicine 342:1301-1308 DOI 10.1056/NEJM200005043421801.
3. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B. 2009. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology 20:1053-1067 DOI 10.1681/ASN.2008070798.
4. Cepkova M, Matthay MA. 2006. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. Journal of Intensive Care Medicine 21:119-143 DOI 10.1177/0885066606287045.
5. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, Kang S, Jin HJ, Yang YS, Park WS. 2009. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplantation 18:869-886 DOI 10.3727/096368909X471189.
6. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1- phosphate. Nature 381:800-803 DOI 10.1038/381800a0.
7. Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS. 2009. Intravenous mesenchymal stem cell therapy for traumatic brain injury. Journal of Neurosurgery 110:1189-1197 DOI 10.3171/2008.9.JNS08158.
8. He X, H'Ng SC, Leong DT, Hutmacher DW, Melendez AJ. 2010. Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. Journal of Molecular Cell Biology 2:199-208 DOI 10.1093/jmcb/mjq011.
9. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. 2008. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Reviews in Molecular Medicine 11:440-452 DOI 10.1017/S1462399409001112.
10. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'Afi RI, Hla T. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312 DOI 10.1016/S0092-8674(00)81661-X.
11. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. 2009. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136:1631-1643 DOI 10.1378/chest.08-2408.
12. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A. 2009. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. American Journal of Pathology 175:303-313 DOI 10.2353/ajpath.2009.080629.
13. Müller-Redetzky HC, Suttorp N, Witzenrath M. 2014. Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives. Cell & Tissue Research 355:657-673 DOI 10.1007/s00441-014-1821-0.
14. Natarajan V, Dudek SM, Jacobson JR, Morenovinasco L, Huang LS, Abassi T, Mathew B, Zhao Y, Wang L, Bittman R. 2013. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. American Journal of Respiratory Cell & Molecular Biology 49:6-17 DOI 10.1165/rcmb.2012-0411TR.
15. Nemeth K, Leelahavanichkul A, Yuen Ps, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. 2008. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine 15:42-49 DOI 10.1038/nm.1905.
16. Ortiz LA, Gambelli F, Mcbride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. 2003. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences of the United States of America 100:8407-8411 DOI 10.1073/pnas.1432929100.
17. Rosen H, Sanna MG, Cahalan SM, Gonzalez-Cabrera PJ. 2007. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends in Immunology 28:102-107 DOI 10.1016/j.it.2007.01.007.
18. Rubenfeld G, Caldwell E, Peabody E, Weaver J, Martin D, Neff M, Stern E, Hudson L. 2005. Incidence and outcomes of acute lung injury. New England Journal of Medicine 353:1685-1693 DOI 10.1056/NEJMoa050333.
19. Sanna MG, Wang SK, Gonzalezcabrera PJ, Don A, Marsolais D, Matheu MP, Wei SH, Parker I, Jo E, Cheng WC. 2006. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chemical Biology 2:434-441 DOI 10.1038/nchembio804.
20. Spiegel S, Milstien S. 2011. The outs and the ins of sphingosine-1-phosphate in immunity. Nature Reviews Immunology 11:403-415 DOI 10.1038/nri2974.
21. Sun X, Singleton PA, Letsiou E, Zhao J, Belvitch P, Sammani S, Chiang ET, Morenovinasco L, Wade MS, Zhou T. 2012. Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. American Journal of Respiratory Cell & Molecular Biology 47:628-636 DOI 10.1165/rcmb.2012-0048OC.
22. Valcz G, Krenács T, Sipos F, Leiszter K, Tóth K, Balogh Z, Csizmadia A, Muzes G, Molnár B, Tulassay Z. 2011. The role of the bone marrow derived mesenchymal stem cells in colonic epithelial regeneration. Pathology and Oncology Research 17:11-16 DOI 10.1007/s12253-010-9262-x.
23. Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS. 2013. Allogeneic mesenchymal stem cell transplantation in severe and refrac- tory systemic lupus erythematosus: 4 years of experience. Cell Transplantation 22:2267-2277 DOI 10.3727/096368911X582769.
24. Wiedemann H, Wheeler A, Bernard G, Thompson B, Hayden D, DeBoisblanc B, Connors A, Hite R, Harabin A. 2006. Comparison of two fluid-management strategies in acute lung injury. New England Journal of Medicine 354:2564-2575 DOI 10.1056/NEJMoa062200.
25. Yu H, Nishi T, Kawahara A. 2012. The functional roles of S1P in immunity. Journal of Biochemistry 152:305-311 DOI 10.1093/jb/mvs090.
26. Zheng Z, Hu L, Ming S, y RX, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S. 2012. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology & Hepatology 27:112-120 DOI 10.1111/j.1440-1746.2011.07024.x.